Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec 30;1(1):426.
doi: 10.1186/1757-1626-1-426.

Primary lymphoma of the head and neck: two case reports and review of the literature

Affiliations

Primary lymphoma of the head and neck: two case reports and review of the literature

Ismail Essadi et al. Cases J. .

Abstract

Background: The head and neck is the second most common region for the extra-nodal lymphomas after that of gastrointestinal tract. Approximately 2.5% of malignant lymphoma arises in the oral and para-oral region. In this paper we report two cases of early stage head and neck lymphoma which were managed successfully with chemotherapy and a review of the related literature.

Cases presentation: The first case concerns a 48 years male patient having a diffuse large B-Cell lymphoma of the oropharynx at early bulky stage. This patient was managed successfully with 7 of Rituximab 375 mg/m2, Cyclophosphamide 750 mg/m2 d1, Doxorubicine 50 mg/m2 d1, Vincristine 1.4 mg/m2 d1, and prednisone 50 mg/m2 d1-5 (RCHOP) regimen. The second case concerns a 50 years female patient having the nasal natural killer (NK)/T-cell lymphoma of the left nasal pit at early stage. This case was managed successfully with 6 of Cyclophosphamide 750 mg/m2 d1, Doxorubicine 50 mg/m2 d1, Vincristine 1.4 mg/m2 d1, and prednisone 50 mg/m2 d1-5 (CHOP) regimen.

Conclusion: These two cases highlight the important role of CHOP based chemotherapy for achieving successful treatment cure for patients having an early stage head and neck lymphoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Right cervical masse fixed, bulky, measured 13 × 10 cm in diameter.
Figure 2
Figure 2
Computed tomography of the head and neck shows the oropharyngeal process and a bulky cervical mass.
Figure 3
Figure 3
Computed tomography of the head and neck shows the involvement of the nasopharynx by the oropharyngeal process.
Figure 4
Figure 4
The right cervical region was free from the disease 22 month after the end of chemotherapy.
Figure 5
Figure 5
NK/T-cell lymphoma, angiocentric infiltrate of small lymphocytes and atypical cells.
Figure 6
Figure 6
Angiocentric marking by CD 56.
Figure 7
Figure 7
Angiocentric marking by CD 3.

Similar articles

Cited by

References

    1. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:519–25. doi: 10.1067/moe.2001.116062. - DOI - PubMed
    1. Kemp S, Gallagher G, Kabani S, Noonan V, O'Hara C. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oeal Surg Oral Pathol Oral Radiol Endod. 2008;105:194–201. doi: 10.1016/j.tripleo.2007.02.019. - DOI - PubMed
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655. doi: 10.1097/00000421-198212000-00014. - DOI - PubMed
    1. Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH. Radiotherapy As Primary Treatment for stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma. J Clin Oncol. 2006;245:181–189. doi: 10.1200/JCO.2005.03.2573. - DOI - PubMed
    1. Solomides CC, Miller AS, Christman RA, Talwar J, Simpkins H. Lymphomas of the oral cavity: histology, immunologic type, and incidence of Epstein-Barr virus infection. Hum Pathol. 2002;33:153–7. doi: 10.1053/hupa.2002.30721. - DOI - PubMed